Summary
Transgenomic Inc (Transgenomic) is a biotechnology company that offers personalized medicine in oncology, cardiology, neurology, and inherited diseases. The company’s products include ICEme Kits, and genetic assays and platforms. Its offers genetic assays and platforms such as chromatography, hanabi cytogenetic systems, genetic analysis kits, PCR reagents, tissue microarray platforms and WAVE DHPLC systems. Transgenomic provides specimen collection kits which include cardiology kits, neurology kits, oncology kits, pharmacogenomic kits, scoliscore AIS prognostic kits and Whole Exome sequencing kits. The company offers patient testing services for cardiology, neurology, mitochondrial disorders and oncology. Transgenomic is headquartered in Omaha, Nebraska, the US.
Transgenomic Inc (TBIO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Transgenomic Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Transgenomic Inc, Medical Devices Deals, 2010 to YTD 2016 9
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Transgenomic Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Transgenomic To Acquire Clinical Sample Biorepository Assets From Gene Logic For US$0.3 Million 11
Transgenomic Completes Acquisition Of Diagnostic Business From Clinical Data 12
Partnerships 14
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 14
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 16
Transgenomic Enters Into Co-Development Agreement With Medical College of Wisconsin 17
Licensing Agreements 18
LabCorp Enters into Licensing Agreement with Transgenomic 18
Transgenomic Expands Licensing Agreement with Exiqon 19
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 20
Equity Offering 21
Transgenomic to Raise up to USD7 Million in Private Placement of Shares 21
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 23
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25
Transgenomic to Raise USD3 Million in Private Placement 27
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 28
Transgenomic Raises USD7 Million in Private Placement of Shares 30
Transgenomic Completes Private Placement Of Shares For US$8 Million 31
Transgenomic Completes Private Placement Of Shares For US$19 Million 33
Transgenomic Completes Private Placement Of Series A Convertible Preferred Stock For US$6 Million 35
Transgenomic Inc - Key Competitors 37
Key Employees 38
Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Tables
Transgenomic Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Transgenomic Inc, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Transgenomic Inc, Deals By Therapy Area, 2010 to YTD 2016 8
Transgenomic Inc, Medical Devices Deals, 2010 to YTD 2016 9
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Transgenomic To Acquire Clinical Sample Biorepository Assets From Gene Logic For US$0.3 Million 11
Transgenomic Completes Acquisition Of Diagnostic Business From Clinical Data 12
Transgenomic Enters Into Co-Marketing Agreement With PerkinElmer For Oncology Diagnostic Test Portfolio 14
Transgenomic Enters Into Co-Development Agreement With Amgen For IVD Test 16
Transgenomic Enters Into Co-Development Agreement With Medical College of Wisconsin 17
LabCorp Enters into Licensing Agreement with Transgenomic 18
Transgenomic Expands Licensing Agreement with Exiqon 19
Transgenomic Enters Into Licensing Agreement With Montefiore Medical 20
Transgenomic to Raise up to USD7 Million in Private Placement of Shares 21
Transgenomic to Raise up to USD3.5 Million in Public Offering of Shares 23
Transgenomic Raises up to USD2.2 Million in Private Placement of Preferred Stock and Warrant 25
Transgenomic to Raise USD3 Million in Private Placement 27
Transgenomic Raises USD7 Million in Public Offering of Shares and Warrants 28
Transgenomic Raises USD7 Million in Private Placement of Shares 30
Transgenomic Completes Private Placement Of Shares For US$8 Million 31
Transgenomic Completes Private Placement Of Shares For US$19 Million 33
Transgenomic Completes Private Placement Of Series A Convertible Preferred Stock For US$6 Million 35
Transgenomic Inc, Key Competitors 37
Transgenomic Inc, Key Employees 38
Transgenomic Inc, Other Locations 39
Transgenomic Inc, Subsidiaries 39
List of Figures
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Transgenomic Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Transgenomic Inc, Medical Devices Deals, 2010 to YTD 2016 9
